CoChat

Exendin-4 attenuates neuronal death via GLP-1R/PI3K/Akt pathway in early brain injury after subarachnoid hemorrhage in rats

Open access
Xie, Zhiyi, Enkhjargal, Budbazar, Wu, Lingyun, Zhou, Keren, Sun, Chengmei, Hu, Xin, Gospodarev, Vadim, Tang, Jiping, You, Chao, Zhang, John H. · 2018 · Neuropharmacology
Cited by 96

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

Neuronal apoptosis is considered to be a crucial therapeutic target against early brain injury (EBI) after subarachnoid hemorrhage (SAH). Emerging evidence indicates that Exendin‐4 (Ex‐4), a glucagon‐like peptide 1 receptor (GLP‐1R) agonist, plays a neuroprotective role in cerebrovascular disease. This study was conducted in order to verify the neuroprotective role of EX‐4 in EBI after SAH in rats. The endovascular perforation model of SAH was performed in Sprague‐Dawley rats (n = 153). Ex‐4 was intraperitoneally injected 1 h after SAH induction in the rats (SAH + Ex‐4). To elucidate the underlying molecular mechanism, small interfering ribonucleic acid (siRNA) for GLP‐1R and a specific inhibitor of PI3K, LY294002, were injected intracerebroventricularly into SAH + Ex‐4 rats before induction of SAH (n = 6 per group). SAH grading evaluation, immunohistochemistry, Western blots, neurobehavioral assessment, and Fluoro‐Jade C (FJC) staining experiments were performed. Expression of GLP‐1R was significantly increased and mainly expressed in neurons at 24 h after SAH induction. Administration of Ex‐4 significantly improved both short‐ and long‐term neurobehavior in SAH + Ex‐4 group compared to SAH + Vehicle group after SAH. Ex‐4 treatment significantly increased the expression of GLP‐1R, PI3K, p‐Akt, Bcl‐xl, and Bcl‐2, while at the same time was found to decrease expression of Bax in the brain. Effects of Ex‐4 were reversed by the intervention of GLP‐1R siRNA and LY294002 in SAH + Ex‐4+GLP‐1R siRNA and SAH + Ex‐4+LY294002 groups, respectively. In conclusion, the neuroprotective effect of Ex‐4 in EBI after SAH was mediated by attenuation of neuronal apoptosis via GLP‐1R/PI3K/Akt signaling pathway, therefore EX‐4 should be further investigated as a potential therapeutic agent in stroke patients. HIGHLIGHTSEx‐4 significantly improved neurological function after SAH.GLP‐1R mainly expressed in neurons after SAH.Ex‐4 did not increased risk of hypoglycemia after SAH in SD rats.Ex‐4 improved spatial learning capacity and reference memory after SAH.The anti‐apoptotic effect of Ex‐4 was mediated via GLP‐1R/PI3K/Akt pathway.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.neuropharm.2017.09.040

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

See all 96

Metadata

Authors
Xie, Z., Enkhjargal, B., Wu, L., Zhou, K., Sun, C., Hu, X., Gospodarev, V., Tang, J., You, C., & Zhang, J. H.
Venue
Neuropharmacology
Publisher
Elsevier BV
Published
2018-01
Volume
128
Pages
142-151
ISSN
0028-3908 (ISSN-L)
OpenAlex
W2762753133
Cited by
96
References
7
FWCI
6.02
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Exendin-4 attenuates neuronal death via GLP-1R/PI3K/Akt pathway in early brain injury after subarachnoid hemorrhage in rats. https://app.cochat.ai/papers/10.1016/j.neuropharm.2017.09.040
The paper
Xie, Z., Enkhjargal, B., Wu, L., Zhou, K., Sun, C., Hu, X., Gospodarev, V., Tang, J., You, C., & Zhang, J. H. (2018). Exendin-4 attenuates neuronal death via GLP-1R/PI3K/Akt pathway in early brain injury after subarachnoid hemorrhage in rats. Neuropharmacology. https://doi.org/10.1016/j.neuropharm.2017.09.040

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.